alpha-aminopyridine has been researched along with Pulmonary Arterial Remodeling in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almonte, VM; Egaña-Gorroño, L; Jayakumar, S; Oliveira-Paula, GH; Parikh, D; Riascos-Bernal, DF; Sibinga, NES; Uriyanghai, U; Zhang, J | 1 |
1 other study(ies) available for alpha-aminopyridine and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
PLX3397, a CSF1 receptor inhibitor, limits allotransplantation-induced vascular remodelling.
Topics: Aminopyridines; Animals; Macrophage Colony-Stimulating Factor; Mice; Protein Kinase Inhibitors; Pyrroles; Receptor Protein-Tyrosine Kinases; Vascular Remodeling | 2022 |